[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]

[[ timeLabel ]] WATCH LIVE:

Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial

Faster, Cleaner, Better.

Taxus Cardium Pharmaceuticals Group (CRXM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2005	09-2005	06-2005	03-2005	12-2004
Cash Flows From Operating Activities
Net Income	-5,442	-525	-319	-31	-66
Depreciation Amortization	12	N/A	N/A	N/A	1
Accounts payable and accrued liabilities	163	115	105	N/A	16
Other Working Capital	422	395	231	-10	13
Other Operating Activity	-121	-73	-63	0	-16
Operating Cash Flow	$-4,967	$-89	$-46	$-41	$-52

Cash Flows From Investing Activities
Change In Deposits	N/A	N/A	N/A	N/A	-12
PPE Investments	-384	N/A	N/A	N/A	N/A
Investing Cash Flow	$-384	$N/A	$N/A	$N/A	$-12

Cash Flows From Financing Activities
Debt Issued	63	63	63	3	N/A
Common Stock Issued	25,562	20	N/A	38	N/A
Other Financing Activity	1,500	0	0	0	0
Financing Cash Flow	$27,125	$83	$63	$41	$N/A

Beginning Cash Position	13	13	13	13	2,686
End Cash Position	21,788	7	30	13	2,622
Net Cash Flow	$21,775	$-6	$17	$N/A	$-64

Free Cash Flow
Operating Cash Flow	-4,967	-89	-46	-41	-52
Capital Expenditure	-384	N/A	N/A	N/A	N/A
Free Cash Flow	-5,350	-89	-46	-41	-52